These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 11062206
1. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. Lemée V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L. J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206 [Abstract] [Full Text] [Related]
2. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Abboud P, Lemée V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lebas F, Caron F, Favennec L. Clin Infect Dis; 2001 Jun 15; 32(12):1792-4. PubMed ID: 11360222 [Abstract] [Full Text] [Related]
3. Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole. Cruz A, Sousa MI, Azeredo Z, Leite E, Figueiredo de Sousa JC, Cabral M. J Antimicrob Chemother; 2003 Apr 15; 51(4):1017-20. PubMed ID: 12654760 [Abstract] [Full Text] [Related]
4. Efficacy of albendazole in giardiasis. Baqai R, Zuberi SJ, Qureshi H, Ahmed W, Hafiz S. East Mediterr Health J; 2001 Apr 15; 7(4-5):787-90. PubMed ID: 15332780 [Abstract] [Full Text] [Related]
5. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. Yereli K, Balcioğlu IC, Ertan P, Limoncu E, Onağ A. Clin Microbiol Infect; 2004 Jun 15; 10(6):527-9. PubMed ID: 15191380 [Abstract] [Full Text] [Related]
6. [Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis]. Cacopardo B, Patamia I, Bonaccorso V, Di Paola O, Bonforte S, Brancati G. Clin Ter; 1995 Dec 15; 146(12):761-7. PubMed ID: 8681495 [Abstract] [Full Text] [Related]
7. Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts. Bernal-Redondo R, Martínez-Méndez LG, Mendoza-Chavez A, Velasco-Perales D, Chavez-Munguia B. J Submicrosc Cytol Pathol; 2004 Dec 15; 36(3-4):241-5. PubMed ID: 15906598 [Abstract] [Full Text] [Related]
8. Secnidazole for control of giardiasis in dairy calves. Volpato A, Fortuoso BF, Campigotto G, Glombowsky P, Bottari NB, Lopes LS, Da Silva AS. Exp Parasitol; 2018 Jun 15; 189():16-18. PubMed ID: 29684664 [Abstract] [Full Text] [Related]
9. Drug susceptibility testing of anaerobic protozoa. Upcroft JA, Upcroft P. Antimicrob Agents Chemother; 2001 Jun 15; 45(6):1810-4. PubMed ID: 11353630 [Abstract] [Full Text] [Related]
10. Development of New PCR Protocols to Detect Genetic Diversity in the Metronidazole Metabolism Genes in Susceptible and Refractory Clinical Samples of Giardia duodenalis. Asghari A, Mahdavi F, Yousefi A, Shamsi L, Badali R, Mohammadi MR, Irannejad H, Mohammadi-Ghalehbin B, Shahabi S, Asgari Q, Motazedian MH, Bastaminejad S. Acta Parasitol; 2024 Mar 15; 69(1):1073-1077. PubMed ID: 38499920 [Abstract] [Full Text] [Related]
11. Induction of albendazole resistance in Giardia lamblia. Lindquist HD. Microb Drug Resist; 1996 Mar 15; 2(4):433-4. PubMed ID: 9158815 [Abstract] [Full Text] [Related]
12. Therapy-resistant diarrhea due to Giardia lamblia in a patient with common variable immunodeficiency disease. Sawatzki M, Peter S, Hess C. Digestion; 2007 Mar 15; 75(2-3):101-2. PubMed ID: 17598960 [No Abstract] [Full Text] [Related]
13. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Hall A, Nahar Q. Trans R Soc Trop Med Hyg; 1993 Mar 15; 87(1):84-6. PubMed ID: 8465408 [Abstract] [Full Text] [Related]
14. Two cases of giardiasis unsuccessfully treated by albendazole. Brasseur P, Favennec L. Parasite; 1995 Dec 15; 2(4):422. PubMed ID: 8745742 [No Abstract] [Full Text] [Related]
15. Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. Alizadeh A, Ranjbar M, Kashani KM, Taheri MM, Bodaghi M. East Mediterr Health J; 2006 Sep 15; 12(5):548-54. PubMed ID: 17333792 [Abstract] [Full Text] [Related]
16. A comparative clinical trial of albendazole versus metronidazole in giardiasis. Misra PK, Kumar A, Agarwal V, Jagota SC. Indian Pediatr; 1995 Mar 15; 32(3):291-4. PubMed ID: 8613282 [Abstract] [Full Text] [Related]
17. Giardia duodenalis mouse model for the development of novel antigiardial agents. Abraham RJ, O'Dea M, Rusdi B, Page SW, O'Handley R, Abraham S. J Microbiol Methods; 2018 Feb 15; 145():7-9. PubMed ID: 29198594 [Abstract] [Full Text] [Related]
18. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial. Leitsch D. Int J Parasitol Drugs Drug Resist; 2017 Dec 15; 7(3):321-327. PubMed ID: 28910741 [Abstract] [Full Text] [Related]
19. In vitro anti-Giardia lamblia activity of 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyridines and -pyrimidines, individually and in combination with albendazole. Velázquez-Olvera S, Salgado-Zamora H, Jiménez-Cardoso E, Campos-Aldrete ME, Pérez-González C, Ben Hadda T. Acta Trop; 2016 Mar 15; 155():6-10. PubMed ID: 26657313 [Abstract] [Full Text] [Related]
20. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Misra PK, Kumar A, Agarwal V, Jagota SC. Indian Pediatr; 1995 Jul 15; 32(7):779-82. PubMed ID: 8617554 [Abstract] [Full Text] [Related] Page: [Next] [New Search]